Prescription of Direct Oral Anticoagulants to Patients with Moderate-to-Advanced CKD: Too Little or Just Right?

S. Liabeuf (1, 2) , S.M. Laville (3) , B. Bieber (4) , C. Tu (4) , B. Stengel (3) , M.M.Y. Wong (4) , V. Calice Da Silva , D. Fliser (5) , B.M. Robinson (4, 6) , R. Pecoits-Filho (4, 7) , Z.A. Massy (3, 8)

1 CHU Amiens-Picardie
2 MP3CV - Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517
3 CESP - Centre de recherche en épidémiologie et santé des populations
4 Arbor Research Collaborative for Health
5 Saarland University [Saarbrücken]
6 University of Michigan [Ann Arbor]
7 PUCPR - Pontifícia Universidade Católica do Paraná
8 Hôpital Ambroise Paré [AP-HP]

No abstract available

Mots clés: CKD; direct oral anticoagulant; oral anticoagulants; vitamin K antagonist

Domaines: Sciences du Vivant [q-bio]

S. Liabeuf, S.M. Laville, B. Bieber, C. Tu, B. Stengel, et al.. Prescription of Direct Oral Anticoagulants to Patients with Moderate-to-Advanced CKD: Too Little or Just Right?. Kidney International Reports, 2021, 6 (9), pp.2496--2500. ⟨10.1016/j.ekir.2021.06.004⟩. ⟨hal-03688195⟩